Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

INDUSTRY 2 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Disease 1

Interventions

Magnetic Resonance Spectroscopy 283 Specimen Handling 278 pembrolizumab 255 Cyclophosphamide 234 Radiotherapy 229 Nivolumab 183 Cisplatin 174 Biopsy 165 Carboplatin 155 Radiosurgery 142 fludarabine 130 Blood Specimen Collection 130 Gemcitabine 120 Surveys and Questionnaires 117 Paclitaxel 115 venetoclax 112 Standard of Care 112 Dexamethasone 105 Bevacizumab 96 Radiation 95 Rituximab 91 Oxaliplatin 89 Cytarabine 88 Capecitabine 86 Drug Therapy 85 Ipilimumab 83 Doxorubicin 81 durvalumab 80 fludarabine phosphate 73 Fluorouracil 72

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × (225)Ac-PSMA-617 × 90 days × Clear all

NCT07054346 2026-04-01

LUTACT

University of California, San Francisco

Phase 1 Recruiting

Disease, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡